Publication not explained
This publication has not yet been explained in plain language by the author(s). However, you can still read the publication.
If you are one of the authors, claim this publication so you can create a plain language summary to help more people find, understand and use it.
Featured Image
Read the Original
This page is a summary of: F317L BCR-ABL1 kinase domain mutation associated with a sustained major molecular response in a CML patient on dasatinib, Leukemia Research, July 2011, Elsevier,
DOI: 10.1016/j.leukres.2011.03.021.
You can read the full text:
Contributors
The following have contributed to this page